Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 8
2004 4
2005 4
2006 6
2007 5
2008 6
2009 6
2010 8
2011 9
2012 3
2013 11
2014 7
2015 9
2016 4
2017 2
2018 5
2019 3
2020 10
2021 9
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Chronic lymphocytic leukemia.
Chiorazzi N, Rai KR, Ferrarini M. Chiorazzi N, et al. Among authors: ferrarini m. N Engl J Med. 2005 Feb 24;352(8):804-15. doi: 10.1056/NEJMra041720. N Engl J Med. 2005. PMID: 15728813 Review. No abstract available.
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.
Morabito F, Tripepi G, Mauro FR, Laurenti L, Reda G, Moia R, Condoluci A, Vincelli I, Chiarenza A, Vigna E, Martino EA, Bruzzese A, Mezzatesta S, Laureana R, Cutrona G, Di Raimondo F, Fronza G, Zucchetto A, Bomben R, Rossi FM, Olivieri J, Zaja F, Rossi D, Gaidano G, Del Principe MI, Ilariucci F, Del Poeta G, Ferrarini M, Neri A, Gattei V, Gentile M. Morabito F, et al. Among authors: ferrarini m. Am J Hematol. 2023 Jul;98(7):E157-E160. doi: 10.1002/ajh.26927. Epub 2023 Apr 17. Am J Hematol. 2023. PMID: 37067157 No abstract available.
CD38 and chronic lymphocytic leukemia: a decade later.
Malavasi F, Deaglio S, Damle R, Cutrona G, Ferrarini M, Chiorazzi N. Malavasi F, et al. Among authors: ferrarini m. Blood. 2011 Sep 29;118(13):3470-8. doi: 10.1182/blood-2011-06-275610. Epub 2011 Jul 15. Blood. 2011. PMID: 21765022 Free PMC article. Review.
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials.
Morabito F, Tripepi G, Del Poeta G, Mauro FR, Reda G, Sportoletti P, Laurenti L, Coscia M, Herishanu Y, Bossio S, Varettoni M, Murru R, Chiarenza A, Visentin A, Condoluci A, Moia R, Pietrasanta D, Loseto G, Consoli U, Scortechini I, Rossi FM, Zucchetto A, Al-Janazreh H, Vigna E, Martino EA, Cassin R, D Arrigo G, Galimberti S, Rago A, Angeletti I, Biagi A, Del Giudice I, Bomben R, Neri A, Fronza G, Monti P, Menichini P, Olivieri J, Cutrona G, Rossi D, Cuneo A, Di Raimondo F, Gaidano G, Polliack A, Trentin L, Foà R, Ferrarini M, Gattei V, Gentile M. Morabito F, et al. Among authors: ferrarini m. Am J Hematol. 2021 Aug 1;96(8):E269-E272. doi: 10.1002/ajh.26201. Epub 2021 May 3. Am J Hematol. 2021. PMID: 33878220 Free article. No abstract available.
The human marginal zone B cell.
Dono M, Zupo S, Colombo M, Massara R, Gaidano G, Taborelli G, Ceppa P, Burgio VL, Chiorazzi N, Ferrarini M. Dono M, et al. Among authors: ferrarini m. Ann N Y Acad Sci. 2003 Apr;987:117-24. doi: 10.1111/j.1749-6632.2003.tb06039.x. Ann N Y Acad Sci. 2003. PMID: 12727630 Review.
Biology and treatment of chronic lymphocytic leukemia.
Keating MJ, Chiorazzi N, Messmer B, Damle RN, Allen SL, Rai KR, Ferrarini M, Kipps TJ. Keating MJ, et al. Among authors: ferrarini m. Hematology Am Soc Hematol Educ Program. 2003:153-75. doi: 10.1182/asheducation-2003.1.153. Hematology Am Soc Hematol Educ Program. 2003. PMID: 14633781 Review.
118 results